Medical CBD research is opening up new possibilities for treatment | The Excerpt
- Apr 7
- 1 min read
Updated: Apr 8
Dana Taylor of USA Today speaks with Dr. Staci Gruber to discuss the current state of medical cannabis research in this episode of The Excerpt. While emerging evidence suggests cannabinoids may offer therapeutic potential for conditions and indications like anxiety, pain, sleep, and epilepsy, the classification of cannabis as a Schedule I drug continues to limit clinical research. Dr. Gruber underscores the need for rigorous scientific evidence to guide the safe and effective use of cannabinoid-based therapies.
Watch the episode below or listen to the podcast here.
Comments